XML 25 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
SHAREHOLDERS' EQUITY
6 Months Ended
Jun. 30, 2017
Stockholders' Equity Note [Abstract]  
SHAREHOLDERS' EQUITY
NOTE 8:-
SHAREHOLDERS' EQUITY

a.
Ordinary shares

The ordinary shares of the Company entitle their holders to receive notice to participate and vote in general meetings of the Company, the right to share in distributions upon liquidation of the Company, and to receive dividends, if declared.

b.
Stock Options, Restricted Stock Units

In 2003, the Company adopted a share option plan (the "Plan"). Under the Plan, options and RSU’s may be granted to officers, directors, employees and consultants of the Company or its subsidiaries. The options vest primarily over four years. The options expire ten years from the date of grant. In December 2012, the Company extended the term of the Plan for an additional period of ten years.

Upon adoption of the Plan, the Company reserved for issuance 8,639,000 ordinary shares in accordance with the respective terms thereof. Any options or RSU’s, which are canceled or forfeited before the expiration date, become available for future grants. As of June 30, 2017, the Company has 1,644,014 Ordinary shares available for future grant under the Plan.

On September 6, 2010, the Company's board of directors amended the Plan so as to enable to grant Restricted share Units ("RSUs") pursuant to such Plan.

The following table summarizes the activities for the Company’s stock options and RSU’s for the six months ended June 30, 2017:
 
   
Number
of options and RSU’s
   
Weighted
average
exercise
price
   
Weighted average remaining contractual term
(in years)
   
Aggregate
intrinsic
value
 
                         
Outstanding at beginning of year
   
7,537,708
   
$
3.84
     
4.93
   
$
6,128
 
Granted
   
141,332
   
$
3.41
                 
Exercised
   
(174,638
)
 
$
1.02
                 
Forfeited or expired
   
(366,019
)
 
$
4.96
                 
                                 
Outstanding at end of the period
   
7,138,383
   
$
3.84
     
4.36
   
$
5,377
 
                                 
Options exercisable at end of the period
   
4,388,313
   
$
5.34
     
3.70
   
$
2,247
 
                                 
Vested and expected to vest
   
6,654,078
   
$
4.01
     
4.32
   
$
4,832
 
 
During the six months ended June 30, 2017, the Company's Board of Directors granted 141,332 options to employees and directors to purchase 141,332 Ordinary shares of the Company. The exercise prices for the options are from $ 2.43 to $ 3.68 per share, with vesting to occur in up to 4 years.

During the six months ended June 30, 2016 and 2017 the Company recorded share based compensation in total amount of $ 592 and $ 619, respectively.

During the year ended December 31, 2016, 72,832 options were exercised at a weighted average exercise price of $ 1.18. In addition, 59,233 Restricted Share Units (RSU’s) were exercised during the year.

During the six months ended June 30, 2017, 150,741 options were exercised at a weighted average exercise price of $ 1.19. In addition, 23,897 RSU’s were exercised during the period.

As of June 30, 2017, the total unrecognized estimated compensation cost related to non-vested stock options granted prior to that date was $ 722, which is expected to be recognized over a weighted average period of approximately one year.